Surgical Science Sweden Stock Current Valuation
| SUSRF Stock | USD 12.75 0.00 0.00% |
Valuation analysis of Surgical Science Sweden helps investors to measure Surgical Science's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Surgical Science's price fluctuation is not too volatile at this time. Calculation of the real value of Surgical Science Sweden is based on 3 months time horizon. Increasing Surgical Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Surgical pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Surgical Science Sweden. Since Surgical Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgical Pink Sheet. However, Surgical Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.75 | Real 12.14 | Hype 12.75 | Naive 12.49 |
The real value of Surgical Pink Sheet, also known as its intrinsic value, is the underlying worth of Surgical Science Sweden Company, which is reflected in its stock price. It is based on Surgical Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Surgical Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Surgical Science Sweden helps investors to forecast how Surgical pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgical Science more accurately as focusing exclusively on Surgical Science's fundamentals will not take into account other important factors: Surgical Science Sweden Company Current Valuation Analysis
Surgical Science's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Surgical Science Current Valuation | 743.09 M |
Most of Surgical Science's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Surgical Science Sweden has a Current Valuation of 743.09 M. This is 94.83% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current valuation for all United States stocks is 95.53% higher than that of the company.
Surgical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgical Science's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics of similar companies.Surgical Science is currently under evaluation in current valuation category among its peers.
Surgical Fundamentals
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Current Valuation | 743.09 M | |||
| Shares Outstanding | 50.8 M | |||
| Shares Owned By Insiders | 32.75 % | |||
| Shares Owned By Institutions | 52.03 % | |||
| Price To Earning | 73.41 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 366.78 M | |||
| Gross Profit | 265.94 M | |||
| EBITDA | 122.27 M | |||
| Net Income | 86.25 M | |||
| Total Debt | 29.42 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 2.66 X | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 0.28 X | |||
| Number Of Employees | 233 | |||
| Beta | 0.94 | |||
| Market Capitalization | 833.72 M | |||
| Total Asset | 3.98 B | |||
| Z Score | 16.8 | |||
| Net Asset | 3.98 B |
About Surgical Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgical Science Sweden's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science Sweden based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.